Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma

ANZ J Surg. 2021 Jun 14. doi: 10.1111/ans.16992. Online ahead of print.
No abstract available